Research Topics
| Leslie IversenSummaryAffiliation: University of Oxford Country: UK Publications
|
Detail Information
Publications
Cannabis and the brainLeslie Iversen
Department of Pharmacology, University of Oxford, Oxford, UK
Brain 126:1252-70. 2003..Medicines based on drugs that enhance the function of endocannabinoids may offer novel therapeutic approaches in the future...
GABA pharmacology--what prospects for the future?Leslie Iversen
Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX13QT, UK
Biochem Pharmacol 68:1537-40. 2004..Gaboxadol (THIP) is an example of a novel hypnotic that acts on GABA-A receptors by a non-benzodiazepine mechanism. Exploiting neurosteroid interactions with GABAergic mechanisms also holds much future promise...
Neurotransmitter transporters and their impact on the development of psychopharmacologyLeslie Iversen
Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT
Br J Pharmacol 147:S82-8. 2006..So far, only one new amino-acid transporter-related drug has become available: the GABA uptake inhibitor tiagabine as a novel antiepileptic agent...
Cannabinoids: a real prospect for pain relief?Leslie Iversen
Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK
Curr Opin Pharmacol 2:50-5. 2002..Development of novel cannabinoid agonists and cannabinoid preparations that are antinociceptive has important implications for the therapeutic use of this class of drugs...
Long-term effects of exposure to cannabisLeslie Iversen
University of Oxford, Department of Pharmacology, Mansfield Road, Oxford OX1 3QT, UK
Curr Opin Pharmacol 5:69-72. 2005..Overall, by comparison with other drugs used mainly for 'recreational' purposes, cannabis could be rated to be a relatively safe drug...
